Prevention
A comprehensive mycoplasma infection prevention platform consisting of preventive vaccines, pre-illness medical care, social system optimization, and infectious disease-resistant medical systems
The unique "MID Prism" measurement technology makes it possible to identify mycoplasma in diseases that were not previously associated with mycoplasma infections.
![Donating Blood](https://static.wixstatic.com/media/8b3713b8bfa24515bc0bcdbdc954e5de.jpg/v1/fill/w_123,h_82,al_c,q_80,usm_0.66_1.00_0.01,blur_2,enc_auto/8b3713b8bfa24515bc0bcdbdc954e5de.jpg)
![Vaccine concept.jpg](https://static.wixstatic.com/media/c8096f_29076b538cfa4e22a5e812a1cd8cd9ad~mv2.jpg/v1/fill/w_460,h_277,al_c,q_80,usm_0.66_1.00_0.01,enc_auto/Vaccine%20concept.jpg)
MID vaccine development
Internationally patented vaccine development technology
The technology to develop "mycoplasma lipid antigen" by chemical synthesis as a vaccine is technology exclusively patented by M Bio Technology.
Expansion to pre-symptomatic medical care
Many diseases are caused by mycoplasma. By knowing the cause, it is possible to propose optimal treatments in the pre-illness state.
The technology to develop "mycoplasma lipid antigen" by chemical synthesis as a vaccine is technology exclusively patented by M Bio Technology.
![ME-BYO concept.png](https://static.wixstatic.com/media/c8096f_a73af25004114de99b96294b81aaa7c5~mv2.png/v1/fill/w_115,h_53,al_c,q_85,usm_0.66_1.00_0.01,blur_2,enc_auto/ME-BYO%20concept.png)